Category: Category 1

The rise of cell and gene therapies (CGT) has introduced groundbreaking treatments, but scaling their manufacturing has proven to be a major hurdle. Traditional production methods have struggled to meet the rising demand for these complex therapies. Enter automation—ushering in a new era where speed, precision, and efficiency redefine the manufacturing process. With robotic systems,…